Abstract. For many diseases, logistic and other constraints often render large incidence studies difficult, if not impossible, to carry out. This becomes a drawback, particularly when a new incidence study is needed each time the disease incidence rate is investigated in a different population. However, by carrying out a prevalent cohort study with follow-up it is possible to estimate the incidence rate if it is constant. In this paper we derive the maximum likelihood estimator (MLE) of the overall incidence rate, λ, as well as age-specific incidence rates, by exploiting the well known epidemiologic relationship, prevalence = incidence × mean duration (P = λ × µ). We establish the asymptotic distributions of the MLEs, provide approximate confidence intervals for the parameters, and point out that the MLE of λ is asymptotically most efficient. Moreover, the MLE of λ is the natural estimator obtained by substituting the marginal maximum likelihood estimators for P and µ, respectively, in the expression P = λ × µ. Our work is related to that of Keiding (1991 Keiding ( , 2006 , who, using a Markov process model, proposed estimators for the incidence rate from a prevalent cohort study without follow-up, under three different scenarios. However, each scenario requires assumptions that are both disease specific and depend on the availability of epidemiologic data at the population level. With follow-up, we are able to remove these restrictions, and our results apply in a wide range of circumstances. We apply our methods to data collected as part of the Canadian Study of Health and Ageing to estimate the incidence rate of dementia amongst elderly Canadians. 
Introduction
In an incidence study, whose goal is to estimate a disease incidence rate, a cohort of initially disease-free subjects is followed forward in time. The subjects are monitored closely and for those who develop the disease their approximate times of disease onset are recorded. Often, as part of an incidence study, these diseased subjects are followed until "failure" or censoring. The data collected from such an incidence study may then be used to directly estimate both the disease incidence rate and the survival function for the time from onset to failure. The estimators of the incidence rate and the survival function from such data are standard.
For many diseases, however, logistic and other constraints often render large incidence studies difficult, if not impossible, to carry out. This becomes a drawback, particularly when a new incidence study is needed each time the disease incidence rate is investigated in a different population. Nevertheless, by carrying out a prevalent cohort study with follow-up it is possible to estimate the incidence rate if it is constant, thus avoiding the problems associated with incidence studies. In this paper we derive the maximum likelihood estimator (MLE) of the overall incidence rate, λ, as well as age-specific incidence rates from data collected as part of a prevalent cohort study with follow-up. We exploit the well known epidemiologic relationship, prevalence = incidence × mean duration (P = λ × µ), to suggest that the likelihood be derived as a function of the vector (P , µ). Once the MLE, (P ,μ) of (P, µ), is obtained, the MLE of λ = P µ follows by invariance. A similar approach may be used to find the MLEs of age specific incidence rates. The asymptotic distributional properties of the estimators may be obtained by modifying previous results for the MLE of the survival function, based on survival data from a prevalent cohort study with follow-up (see Section 4) . It is comforting that the MLEλ =P µ is, therefore, also the natural ad hoc estimator of λ.
In a medical setting, a prevalent cohort study with follow-up (Wang 1991) begins with the identification, from a sampled cohort, of those with existing (prevalent) disease.
The dates of onset for the diseased are ascertained and the diseased subjects are followed forward in time until failure or censoring. Other data collected include the ages at the time of recruitment, the failure/censoring times of the subjects who are followed, and covariates of interest to the researchers. There are two main features of the data collected from such studies. First, the dates of disease onset of the prevalent cases do not include the dates of onset of those who died prior to the start of the prevalent cohort study;
we can only speculate as to the existence of such subjects. Hence, direct use of the observed dates of onset from a prevalence study, in contrast to dates of onset from an incidence study, leads to underestimation of the true incidence rate. Second, the observed failure/censoring intervals are left-truncated and, if the underlying incidence process is stationary, as is the assumption here, they are length biased; those with longer survival intervals are more likely to be observed (Wicksell 1925 , Neyman 1955 , Cox 1969 , Patil and Rao 1978 , and Vardi 1982 , 1985 . We address these difficulties in deriving the MLE (P ,μ) and hence the MLEλ, of the overall incidence rate. We use a similar approach to the estimation of age-specific incidence rates. Keiding (1991 Keiding ( , 2006 used a Markov process model to derive carefully, the prevalenceincidence relationship, and proposed three different scenarios which facilitate estimation of the (constant) age-specific incidence rate when there are no follow-up data. In the first scenario it is assumed that there is non-differential mortality for the diseased and non-diseased. In Biering-Sorensen and Hilden (1984) this assumption is likely to be tenable while in Keiding et al. (1989) , it is probably not, since the disease under study is diabetes. In the second scenario, which Keiding invokes in his 1989 paper, no assumption of non-differential mortality is made. It is either assumed that the incidence rate is small and that the difference between the intensities from the healthy and diseased states to death is known or that the difference between these two intensities is small and known. In the third scenario, it is assumed that the joint relative intensity of the calendar time, age-and duration-specific mortality is known. Under each scenario a parametric assumption must be made, and in the last two scenarios certain population parameters must be known. Therefore, these estimators are strongly disease-specific and also dependent on the availability of certain population level data. These assumptions are needed to compensate for not having follow-up information. By following-up the prevalent cases we are able to avoid these assumptions. Our main assumption is that the underlying incidence process is a stationary Poisson process, an assumption that Keiding also makes. Stationarity of the incidence rate holds, roughly, for many diseases:
for example, amyotrophic lateral sclerosis (Sorenson et al. 2002) , certain types of cancers (Jemal et al. 2005) , and schizophrenia (Folnegovic and Folnegovic-Smalc 1992 to estimate a general incidence rate. To our knowledge there is no literature that provides a general framework for maximum likelihood estimation of a constant underlying incidence rate when one has access only to prevalent cohort survival data with follow-up.
The rest of this paper is organized as follows: In Section 2 we provide a careful formulation of a prevalent cohort study with follow-up, paying particular attention to survival data. In Section 3 we discuss the MLE for the underlying incidence rate. In Section 4, we present the asymptotic properties of the estimator, paving the way for computation of an approximate confidence interval for the underlying incidence rate. In Section 5 we extend our results to include age-specific incidence rates. In Section 6 we apply our methods to data collected as part of the Canadian Study of Health and Aging (CSHA), in order to estimate the underlying age-specific incidence rates of dementia amongst the elderly in Canada.
General setup and notation
Let X 1 , X 2 , ..., X m be m i.i.d. positive random variables representing the survival times of individuals from onset of a disease, say, to an end point of interest. Let the X i 's have survivor function S(x) = P (X i > x), cumulative distribution function F (x), and probability density function f (x). Define µ to be the mean survival time; that is, µ = 
Point estimation of the incidence rate
Under stationarity we assume the underlying incidence process is a Poisson process with constant intensity λ(t) ≡ λ. Hence, the truncation time distribution, G, is uniform, conditional on the number of incident times in (0, τ * ) (Asgharian, Wolfson, and Zhang
2006).
We begin by deriving the MLE of λ. We then derive the MLE of the age-specific incidence rates. The approach depends on the well-known relationship, P = λ × µ where P is the time-independent point prevalence, λ is the time-independent underlying incidence rate, and µ is the mean duration of the disease (see Keiding 1991) . 
practice, the data of a prevalent cohort study with follow-up are collected in two stages.
In stage 1, a binary, 0-1, random variable, say ξ, is measured on each randomly selected subject to ascertain if the subject has experienced initiation of the disease. In stage 2, we observe the triple (
.., n on diseased subjects, indicated by ξ = 1. The following tree diagram depicts our sampling scheme: The full likelihood is:
where P = P (ξ = 1) is the time-independent point prevalence in the population. For the derivation of a similar likelihood see Asgharian and Wolfson (2005) . As is readily seen, the above likelihood can be factorized as
Joint maximization of (2) with respect to S and P gives the NPMLE (Ŝ,P ) and hence the NPMLE (μ,P ) whereP = N/s is the usual point prevalence estimator of P . It follows, by invariance, thatλ =P /μ is the unconditional NPMLE of λ. It is seen that λ, the MLE, is also the natural ad hoc estimator derived from the relation λ = P/µ, by replacing P and µ by their respective natural estimators.
Wang (1991) derived the NPMLEĜ of G, the truncating distribution, by conditioning on the observed backward recurrence times. Although, under stationarity, G is uniform, and this observation allows one to informally assess stationarity, it does not lead to an estimate of λ, since λ is not uniquely determined by G.
Interval estimation of the incidence rate
To derive an asymptotic confidence interval for λ we begin with the asymptotic properties of (λ,P ) which in turn requires a careful examination of the likelihood (2).
Identity (4) of Lemma 1, though simple, plays a key role in the derivation of an asymptotic confidence interval for λ as it facilitates the transferral of the asymptotic properties ofμ andP to those ofλ. Lemma 1. Let λ, P, and µ be respectively, the time-independent underlying incidence rate, the time-independent point prevalence and the mean duration of the disease. Letμ andP be the unconditional MLEs of µ and P respectively. Defineλ =P µ , the MLE of
Proof. The result follows immediately from the definitions of λ andλ. = O log log s s
where
and ψ(u, v) is the covariance function of the limiting process ofŜ. 5. Estimating the age-specific incidence rate
For many diseases the incidence rate is age-dependent, and estimators of age-specific incidence rates are almost always sought by epidemiologists. Following the notation from Section 2, let τ * represent the calendar time of recruitment, let X be the time from onset to death, and τ o be the calendar time of onset. Let D t be the event of being diseased and alive at time t, let A o be the age at onset, and A t the age at calendar time t. We assume that the distribution of X does not change with calendar time, and that both A o and A t are discrete random variables; the latter assumption can be relaxed to include arbitrary random variables. Then,
On the other hand, we have
We also note that
Having assumed that dP τo|At (t | z)/dt = λ z only depends on z, we obtain
We thus find the age-specific incidence
It follows by invariance that the MLE of λ z is
is the observed proportion in the recruited cohort who are diseased and with age-at-onset z. Note that to findŜ z we begin by restricting our attention to the length-biased survival/censoring times of the prevalent cases, whose onset occurred at age z. ThenŜ z is the MLE of S z , based on these length-biased data, as derived by
Asgharian et al. (2002) and Asgharian and Wolfson (2005).
It is assumed that the population age distribution {P (A t = z)} z , may be routinely obtained from census data. Since census data are usually only updated every five years, a reasonable assumption is that P (A t = z) is piecewise constant as a function of t.
However, as we shall see in Section 6 it might be possible to make the even stronger assumption that P (A t = z) = P (A = z), is roughly independent of t, without affectinĝ λ z substantially. An alternative which requires more intensive modeling, is to replace the step function P (A t = z) by a smooth function of t. We suggest that the extra effort would probably result in very small improvement if any.
Since, in Section 6, the population age distribution is assumed to be constant we restrict our attention to this case. Then equation (5) reduces to
where P (A = z) is the proportion of subjects in age category z, and µ z represents the mean survival time in age category z. The information contained in the observations, for the case of three age categories (z = 1, 2, 3), may be illustrated through the following tree diagram, 
Using equation (7),
is the MLE of λ z , whereμ z is the MLE of µ z derived fromŜ z .
Estimating the incidence rate of dementia
In 1991, 10,263 elderly Canadians (65 years or older), living at home or in an institution, were screened for dementia (CSHA working group 1994). This phase of the study was known as CSHA-1. At the time of CSHA-1, 821 subjects were classified as having either possible Alzheimer's disease, probable Alzheimer's disease, or vascular dementia. Henceforth, by the term dementia we mean having exactly one of these three conditions since they constitute the vast majority of dementias. The approximate dates of onset were derived in a hierarchical fashion from the answers to three questions (Wolfson et al. 2001 ). In 1996, the second phase of the study, CSHA-2, was completed.
CSHA-2 included the ascertainment of the date of death or right censoring for those cases identified at CSHA-1. These are the data upon which we shall base our estimates of the overall and age-specific incident rates of dementia. However, additional data were, in fact, collected as part of the CSHA with the goal of estimating the age-specific incidence rates of dementia among elderly Canadians. The subjects who were deemed not to have dementia at CSHA-1 were re-evaluated for dementia at CSHA-2. Assuming that these incidence rates had remained constant, they were estimated using the incident cases observed between CSHA-1 and CSHA-2. There were nevertheless, difficulties with these "incident" data since it could not be ascertained with certainty whether those who had died between CSHA-1 and CSHA-2 had become incident cases with dementia.
In this paper we, therefore, re-estimated the incidence rates without relying on the "incident" cases that occurred between CSHA-1 and CSHA-2. The assumption of a roughly constant incidence rate for dementia has been previously checked in several ways and has been deemed to be reasonable (see Asgharian et al. 2002 . This gives an estimate for P of 0.066 (CSHA working group 1994), which leads to a point estimate,λ = 0.0139, or 13.9 per 1,000 person-years.
To obtain an interval estimate for λ, we followed the bootstrap procedure and sampled with replacement from the 10,263 screened subjects to obtain 10,000 bootstrap samples of the same size. We obtained a confidence interval for λ of [12.52, 15 .28] cases per 1,000
person-years.
6.2. Estimating the age-specific incidence rate of dementia. Three age groups were considered for the CSHA data: 65-74, 75-84, and 85+ years old. The 821 cases of dementia were subdivided as follows: 164 had onset between 65 and 74 years old, 381
had onset between 75 and 84 years old, and 276 were 85 or older when they had onset.
The estimated mean survival times in years were 7.97, 5.16, and 3.50, for the 65-74, 75-84, and 85+ groups, respectively. To use equation (9), we require an approximately stable age distribution over the period covering the onset times. We consulted data from four Canadian censuses covering 1976-1991 to assess this assumption. and 1991 censuses, we also computed some measures of variability for the percentage in each of the three age groups. These are presented in Table 1 . Having verified that the age distribution is roughly stable for this time period, we proceeded with the age-specific incidence estimation using the 1991 census data. Amongst those 65 years or older in 1991, 59.8% were in the 65-74 group, 31.3% were in the 75-84 group, and 8.9% were in the 85+ group (Statistics Canada 2006). The resulting agespecific incidence rate estimates are presented in Table 2 . In 1976, amongst those 65 years or older, 62.7% were in the 65-74 group, 29.1% were in the 75-84 group, and 8.2%
were in the 85+ group (Statistics Canada 2006). We also estimated the age-specific incidence rates based on the census age distribution data from 1976 to take into account small changes in the population age distribution that might have occurred over the period from 1976 to 1991. When the age distribution changes, this approach provides a simple framework for investigating robustness of the age-specific incidence rate estimator to departures from the assumption of constancy of the age distribution. For comparative purposes, the age-specific incidence rate estimates based on the 1976 census data are also given in Table 2 . whether those who had died in this time period had had onset of Alzheimer's disease (possible or probable). As a result, incidence rates of Alzheimer's disease reported from the CSHA were underestimates of the true incidence rates amongst elderly Canadians since they were based only on subjects who survived until the end of CSHA-2 in 1996.
The CSHA incidence rate estimates of Alzheimer's disease were 7.4 and 5.9 per 1,000
person-years for women and men respectively (CSHA working group 2000), giving a crude estimated incidence rate for men and women combined of 6. what is taken as the population age distribution.
Concluding remarks
Simulations, whose results are not reported in this paper, suggest that our methods work well for moderate sample sizes; the asymptotic distribution of the estimated incidence rates were close to Normal, the point estimates were close to their true values and the confidence intervals reasonably narrow for a range of parameter choices.
Our estimator of the incidence rate depends on the estimatorŜ, for the survival function S. We propose that the most efficient estimator for S, under the assumption of a constant incidence rate, should be used. The estimator,Ŝ, used in this paper is more efficient than the well-known estimator of S for general left truncation data (Wang 1991) which does not invoke stationarity of the incidence process (Asgharian et al. 2002 ).
Indeed, it is possible to show that the estimators we present for the incidence rates The CSHA data used for illustration is based on an initial cohort of 10,263 subjects obtained as a stratified cluster sample whereby a fixed number of institutionalized (about 10%) and non-institutionalized (about 90%) subjects were sampled. In addition, those over 85 years old were over-sampled. We do not take into account the sampling scheme in our estimated incidence rates or in the asymptotic distributions of our estimators. To do so requires development of new theory allowing for within cluster dependence, which is a topic for further study and is not directly pertinent to our methods. We would also like to thank the referees and Associate Editor for their useful comments and suggestions which helped greatly enhance our paper.
Appendix
We provide a road map of the proof of Theorem 1 and give further details about steps (iv) and (v) below. Road map of the proof:
(i) Establish the asymptotic behavior ofF LB .
(ii) Establish the asymptotic behavior ofF using (i).
(iii) Establish the asymptotic behavior ofμ using (ii).
(iv) Establish the independence ofμ andP .
(v) Establish the asymptotic behavior ofλ using (4), (iii), and (iv).
The derivation of (i) is similar to its counterpart given by Asgharian and Wolfson (2005) , and those of (ii) and (iii) are similar to their counterparts in Asgharian et al. (2002) .
The expressions, however, are slightly different in view of the different sampling scheme under consideration here. We therefore sketch the proof of steps (iv) and (v).
Step(iv):
In this step we justify the independence ofP andF , and hence ofP andμ. This independence is suggested by the likelihood factorization (3). Theorem 2 shows that this is in fact the case. First, observe that it follows from (2) thatP = Under the assumptions of Theorem 1
where U is given in Theorem 1 and W ∼ N(0, P (1 − P )) is independent of U. Step(v):
In this final step we combine the results of steps (i) through (iii), in Theorem 1, to yield the asymptotic behaviour ofλ. 
